{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:51:50Z","timestamp":1761706310419,"version":"3.40.4"},"publisher-location":"Dordrecht","reference-count":62,"publisher":"Springer Netherlands","isbn-type":[{"type":"print","value":"9789400779198"},{"type":"electronic","value":"9789400779204"}],"license":[{"start":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T00:00:00Z","timestamp":1386720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T00:00:00Z","timestamp":1386720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-94-007-7920-4_4","type":"book-chapter","created":{"date-parts":[[2013,12,28]],"date-time":"2013-12-28T11:58:25Z","timestamp":1388231905000},"page":"49-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Amide-Type Adduct of Dopamine \u2013 Plausible Cause of Parkinson Diseases"],"prefix":"10.1007","author":[{"given":"Xuebo","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruomi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,11]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1242\/dev.02501","volume":"133","author":"SL Ang","year":"2006","unstructured":"Ang SL (2006) Transcriptional control of midbrain dopaminergic neuron development. Development 133:3499\u20133506","journal-title":"Development"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03033137","volume":"5","author":"M Asanuma","year":"2003","unstructured":"Asanuma M, Miyazaki I, Ogawa N (2003) Dopamine- or L-DOPA-induced Neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson\u2019s disease. Neurotox Res 5:165\u2013176","journal-title":"Neurotox Res"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","volume":"120","author":"RS Balaban","year":"2005","unstructured":"Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120:483\u2013495","journal-title":"Cell"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1385\/MN:26:2-3:283","volume":"26","author":"NG Bazan","year":"2002","unstructured":"Bazan NG, Palacios-Pelaez R, Lukiw WJ (2002) Hypoxia signaling to genes: significance in Alzheimer\u2019s disease. Mol Neurobiol 26:283\u2013298","journal-title":"Mol Neurobiol"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11745-005-1377-1","volume":"40","author":"C Beermann","year":"2005","unstructured":"Beermann C, M\u00f6bius M, Winterling N, Schmitt JJ, Boehm G (2005) sn-position determination of phospholipid-linked fatty acids derived from erythrocytes by liquid chromatography electrospray ionization ion-trap mass spectrometry. Lipids 40:211\u2013218","journal-title":"Lipids"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","volume":"73","author":"SB Berman","year":"1999","unstructured":"Berman SB, Hastings TG (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson\u2019s disease. J Neurochem 73:1127\u20131137","journal-title":"J Neurochem"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","volume":"2","author":"J Bove","year":"2005","unstructured":"Bove J, Prou D, Perier C, Przedborski S (2005) Toxin-induced models of Parkinson\u2019s disease. NeuroRx 2:484\u2013494","journal-title":"NeuroRx"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/iub.46","volume":"60","author":"A Boveris","year":"2008","unstructured":"Boveris A, Navarro A (2008) Brain mitochondrial dysfunction in aging. IMUBM Life 60:308\u2013314","journal-title":"IMUBM Life"},{"key":"4_CR90","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.nbd.2003.10.003","volume":"15","author":"C Buhmann","year":"2004","unstructured":"Buhmann C, Arlt S, Kontush A, Moeller-Bertram T, Sperber S, Oechsner M, Stuerenburg HJ, Beisiegel U (2004) Plasma and CSF markers of oxidative stress are increased in Parkinson\u2019s disease and influenced by antiparkinsonian medication. Neurobiol Dis 15:160\u2013170","journal-title":"Neurobiol Dis"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"17870","DOI":"10.1074\/jbc.M602632200","volume":"281","author":"EM Chalovich","year":"2006","unstructured":"Chalovich EM, Zhu JH, Caltagarone J, Bowser R, Chu CT (2006) Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells. J Biol Chem 281:17870\u201317881","journal-title":"J Biol Chem"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1742-4658.2005.05103.x","volume":"273","author":"C Chinopoulos","year":"2006","unstructured":"Chinopoulos C, Adam-Vizi V (2006) Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J 273:433\u2013450","journal-title":"FEBS J"},{"key":"4_CR120","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson\u2019s disease. J Neurochem 52:381\u2013389","journal-title":"J Neurochem"},{"key":"4_CR130","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/mds.870090115","volume":"9","author":"DT Dexter","year":"1994","unstructured":"Dexter DT, Holley AE, Filtter WD, Slater TF, Wells FR, Daniel SE, Lees A, Jenner P, Marsden CD (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord 9:92\u201397","journal-title":"Mov Disord"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/bj3010721","volume":"301","author":"E Diez","year":"1994","unstructured":"Diez E, Chilton FH, Stroup G, Mayer RJ, Winkler JD, Fonteh AN (1994) Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate. Biochem J 301:721\u2013726","journal-title":"Biochem J"},{"key":"4_CR150","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/ana.410320616","volume":"32","author":"S Fahn","year":"1992","unstructured":"Fahn S, Cohen G (1992) The oxidant stress hypothesis in Parkinson\u2019s disease: evidence supporting it. Ann Neurol 32:804\u2013812","journal-title":"Ann Neurol"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1073\/pnas.93.10.4765","volume":"93","author":"MJ Forster","year":"1996","unstructured":"Forster MJ, Dubey A, Dawson KM, Stutts WA, Lal H, Sohal RS (1996) Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Natl Acad Sci USA 93:4765\u20134769","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.clinph.2008.03.017","volume":"119","author":"A Galvan","year":"2008","unstructured":"Galvan A, Wichmann T (2008) Pathophysiology of parkinsonism. Clin Neurophysiol 119:1459\u20131474","journal-title":"Clin Neurophysiol"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.tips.2006.05.003","volume":"27","author":"U Gethe","year":"2006","unstructured":"Gethe U, Andersen PH, Larsson OM, Schousboe A (2006) Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol Sci 27:375\u2013383","journal-title":"Trends Pharmacol Sci"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000017460","volume":"22","author":"AM Gorman","year":"2000","unstructured":"Gorman AM, Ceccatelli S, Orrenius S (2000) Role of mitochondria in neuronal apoptosis. Dev Neurosci 22:348\u2013358","journal-title":"Dev Neurosci"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0163-7258(94)90055-8","volume":"63","author":"ME Gotz","year":"1994","unstructured":"Gotz ME, Kunig G, Riederer P, Youdim MB (1994) Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 63:37\u2013122","journal-title":"Pharmacol Ther"},{"key":"4_CR18","first-page":"573","volume":"54","author":"R Graumann","year":"2002","unstructured":"Graumann R, Paris I, Martinez-Alvarado P, Rumanque P, Perez-Pastene C, Cardenas SP, Marin P, Diaz-Grez F, Caviedes R, Caviedes P, Segura-Aguilar J (2002) Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson\u2019s disease. Possible neuroprotective role of DT-diaphorase. Pol J Pharmacol 54:573\u2013579","journal-title":"Pol J Pharmacol"},{"key":"4_CR19","first-page":"101","volume":"36","author":"M Hadders-Algra","year":"2008","unstructured":"Hadders-Algra M (2008) Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J Perinat Med 36:101\u2013109","journal-title":"J Perinat Med"},{"key":"4_CR20","first-page":"154","volume":"176","author":"A Hald","year":"2005","unstructured":"Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson\u2019s disease: is there a causal link? Exp Neurol 176:154\u2013162","journal-title":"Exp Neurol"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1074\/jbc.M511560200","volume":"281","author":"K Hanrott","year":"2006","unstructured":"Hanrott K, Gudmunsen L, O'Neill MJ, Wonnacott S (2006) 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J Biol Chem 281:5373\u20135382","journal-title":"J Biol Chem"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/jnr.20382","volume":"79","author":"Y Izumi","year":"2005","unstructured":"Izumi Y, Sawada H, Sakka N, Yamamoto N, Kume T, Katsuki H, Shimohama S, Akaike A (2005) p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. J Neurosci Res 79:849\u2013860","journal-title":"J Neurosci Res"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1002\/ana.10483","volume":"53","author":"P Jenner","year":"2003","unstructured":"Jenner P (2003) Oxidative stress in Parkinson\u2019s disease. Ann Neurol 53:S26\u2013S38","journal-title":"Ann Neurol"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.brainres.2007.12.044","volume":"1197","author":"Z Jia","year":"2008","unstructured":"Jia Z, Zhu H, Misra HP, Li Y (2008) Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxy-2-nonenal, or hydrogen peroxide. Brain Res 1197:159\u2013169","journal-title":"Brain Res"},{"key":"4_CR27","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0022-2275(20)37417-4","volume":"38","author":"Y Kato","year":"1997","unstructured":"Kato Y, Makino Y, Osawa T (1997) Formation of N \u03b5-(hexanonyl) lysine in protein exposed to lipid hydroperoxide A plausible marker for lipid hydroperoxide-derived protein modification. J Lipid Res 38:1334\u20131346","journal-title":"J Lipid Res"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"20406","DOI":"10.1074\/jbc.274.29.20406","volume":"274","author":"Y Kato","year":"1999","unstructured":"Kato Y, Mori Y, Makino Y, Morimitsu Y, Hiroi S, Ishikawa T, Osawa T (1999) Formation of N \u03b5-(hexanonyl) lysine in protein exposed to lipid hydroperoxide A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 274:20406\u201320414","journal-title":"J Biol Chem"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1006\/abbi.1997.0519","volume":"351","author":"Y Kato","year":"1998","unstructured":"Kato Y, Osawa T (1998) Detection of oxidized phospholipid-protein adducts using anti-15-hydroperoxyeicosatetraenoic acid-modified protein antibody: contribution of esterified fatty acid-protein adduct to oxidative modification of LDL. Arch Biochem Biophys 351:106\u2013114","journal-title":"Arch Biochem Biophys"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bbrc.2003.11.123","volume":"313","author":"Y Kawai","year":"2004","unstructured":"Kawai Y, Fujii H, Kato Y, Kodama M, Naito N, Uchida K, Osawa T (2004) Esterified lipid hydroperoxide-derived modification of protein: formation of a carboxyalkylamide-type lysine adduct in human atherosclerotic lesions. Biochem Biophys Res Commun 313:271\u2013276","journal-title":"Biochem Biophys Res Commun"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1194\/jlr.M600091-JLR200","volume":"47","author":"Y Kawai","year":"2006","unstructured":"Kawai Y, Fujii H, Okada M, Tsuchie Y, Uchida K, Osawa T (2006) Formation of Nepsilon-(succinyl)lysine in vivo: a novel marker for docosahexaenoic acid-derived protein modification. J Lipid Res 47:1386\u20131398","journal-title":"J Lipid Res"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1194\/jlr.M200442-JLR200","volume":"44","author":"Y Kawai","year":"2003","unstructured":"Kawai Y, Kato Y, Fujii H, Mkino Y, Mori Y, Naito N, Osawa T (2003) Immunochemical detection of a novel lysine adduct using an antibody to linoleic acid hydroperoxide-modified protein. J Lipid Res 44:1124\u20131131","journal-title":"J Lipid Res"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1254\/jphs.92.178","volume":"92","author":"T Kita","year":"2003","unstructured":"Kita T, Wagner GC, Nakashima T (2003) Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 92:178\u2013195","journal-title":"J Pharmacol Sci"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1126\/science.275.5303.1132","volume":"275","author":"RM Kluck","year":"1997","unstructured":"Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132\u20131136","journal-title":"Science"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1046\/j.1471-4159.1999.0732546.x","volume":"73","author":"MJ LaVoie","year":"1999","unstructured":"LaVoie MJ, Hastings TG (1999) Peroxynitrite\u2010and nitrite\u2010induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. J Neurochem 73:2546\u20132554","journal-title":"J Neurochem"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"9986","DOI":"10.1074\/jbc.M800426200","volume":"283","author":"YM Lee","year":"2008","unstructured":"Lee YM, Park SH, Shin DI, Hwang JY, Park B, Park YJ, Lee TH, Chae HZ, Jin BK, Oh TH, Oh YJ (2008) Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. J Biol Chem 283:9986\u20139998","journal-title":"J Biol Chem"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH (1998) The ubiquitin pathway in Parkinson\u2019s disease. Nature 395:451\u2013452","journal-title":"Nature"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"433","author":"MT Lin","year":"2006","unstructured":"Lin MT, Flint BM (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 433:787\u2013795","journal-title":"Nature"},{"key":"4_CR400","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3164\/jcbn.2008040","volume":"43","author":"XB Liu","year":"2008","unstructured":"Liu XB, Shibata T, Hisaka S, Osawa T (2008) DHA hydroperoxides as a potential inducer of neuronal cell death: a mitochondrial dysfunction-mediated pathway. J Clin Biochem Nutr 43:26\u201333","journal-title":"J Clin Biochem Nutr"},{"key":"4_CR410","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1471-4159.2007.05175.x","volume":"105","author":"EK Long","year":"2008","unstructured":"Long EK, Murphy TC, Leiphon LJ, Watt J, Morrow JD, Milne GL, Howard JR, Picklo MJ Sr (2008) Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation. J Neurochem 105:714\u2013724","journal-title":"J Neurochem"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"14299","DOI":"10.1523\/JNEUROSCI.3593-07.2007","volume":"27","author":"QL Ma","year":"2007","unstructured":"Ma QL, Teter B, Ubeda OJ, Morihara T, Dhoot D, Nyby MD, Tuck ML, Frautschy SA, Cole GM (2007) Omega-3 fatty acid docosahexaenoic acid increases SorLA\/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. J Neurosci 27:14299\u201314307","journal-title":"J Neurosci"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.brainres.2005.09.041","volume":"1063","author":"H Maharaj","year":"2005","unstructured":"Maharaj H, Mahara DS, Scheepers M, Mokokong R, Daya S (2005) l-DOPA administration enhances 6-hydroxydopamine generation. Brain Res 1063:180\u2013186","journal-title":"Brain Res"},{"key":"4_CR440","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jchromb.2005.04.023","volume":"827","author":"E Mariani","year":"2005","unstructured":"Mariani E, Polidori MC, Cherubini A, Mecocci P (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B 827:65\u201375","journal-title":"J Chromatogr B"},{"issue":"Suppl 2","key":"4_CR450","first-page":"6","volume":"249","author":"W Maruyama","year":"2002","unstructured":"Maruyama W, Naoi M (2002) Cell death in Parkinson\u2019s disease. J Neurol 249(Suppl 2):6\u201310","journal-title":"J Neurol"},{"key":"4_CR460","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.chemphyslip.2003.10.010","volume":"128","author":"KS Montine","year":"2004","unstructured":"Montine KS, Quinn JF, Zhang J, Fessel JP, Roberts LJ 2nd, Morrow JD, Montine TJ (2004) Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem Phys Lipids 128:117\u2013124","journal-title":"Chem Phys Lipids"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"C670","DOI":"10.1152\/ajpcell.00213.2006","volume":"292","author":"A Navarro","year":"2007","unstructured":"Navarro A, Boveris A (2007) The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 292:C670\u2013C686","journal-title":"Am J Physiol Cell Physiol"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1021\/jm970099t","volume":"40","author":"A Pezzella","year":"1997","unstructured":"Pezzella A, d\u2019Ischia M, Napolitano A, Misuraca G, Prota G (1997) Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson\u2019s disease. J Med Chem 40:2211\u20132216","journal-title":"J Med Chem"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF02536034","volume":"30","author":"NA Porter","year":"1995","unstructured":"Porter NA, Caldwell SE, Mills KA (1995) Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30:277\u2013290","journal-title":"Lipids"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1385-299X(03)00057-6","volume":"12","author":"Y Qu","year":"2003","unstructured":"Qu Y, Chang L, Klaff J, Seeman R, Balbo A, Rapoport SI (2003) Imaging of brain serotonergic neurotransmission involving phospholipase A2 activation and arachidonic acid release in unanesthetized rats. Brain Res Brain Res Protoc 12:16\u201325","journal-title":"Brain Res Brain Res Protoc"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1023\/A:1022584707352","volume":"24","author":"SI Rapoport","year":"1999","unstructured":"Rapoport SI (1999) In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling. Neurochem Res 24:1403\u20131415","journal-title":"Neurochem Res"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1046\/j.1471-4159.2003.02246.x","volume":"88","author":"TA Rosenberger","year":"2004","unstructured":"Rosenberger TA, Villacreses NE, Hovda JT, Bosetti F, Weerasinghe G, Wine RN, Harry GJ, Rapoport SI (2004) Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J Neurochem 88:1168\u20131178","journal-title":"J Neurochem"},{"key":"4_CR46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0026-895X(25)12658-8","volume":"7","author":"A Saner","year":"1970","unstructured":"Saner A, Thoenen H (1970) Model experiments on the molecular mechanism of action of 6-hydroxydopamine. Mol Pharmacol 7:147\u2013154","journal-title":"Mol Pharmacol"},{"key":"4_CR47","first-page":"155","volume":"86","author":"AH Schapira","year":"2001","unstructured":"Schapira AH (2001) Causes of neuronal death in Parkinson\u2019s disease. Adv Neurol 86:155\u2013162","journal-title":"Adv Neurol"},{"key":"4_CR550","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jnr.10777","volume":"74","author":"M Shamoto-Nagai","year":"2003","unstructured":"Shamoto-Nagai M, Maruyama W, Kato Y, Isobe K, Tanaka M, Naoi M, Osawa T (2003) An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J Neurosci Res 74:589\u2013597","journal-title":"J Neurosci Res"},{"key":"4_CR560","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1074\/jbc.M509065200","volume":"281","author":"T Shibata","year":"2006","unstructured":"Shibata T, Iio K, Kawai Y, Shibata Y, Kawaguchi M, Toi S, Kobayashi M, Kobayashi M, Yamamoto K, Uchida K (2006) Identification of a lipid peroxidation product as a potential trigger of the p53 pathway. J Biol Chem 281:1196\u20131204","journal-title":"J Biol Chem"},{"key":"4_CR570","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1021\/bi061853s","volume":"46","author":"SJ Siegel","year":"2007","unstructured":"Siegel SJ, Bieschke J, Powers ET, Kelly JW (2007) The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation. Biochemistry 46:1503\u20131510","journal-title":"Biochemistry"},{"issue":"Suppl","key":"4_CR48","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/ajcn\/70.3.560s","volume":"70","author":"AP Simopoulos","year":"1999","unstructured":"Simopoulos AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70(Suppl):560\u2013569","journal-title":"Am J Clin Nutr"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0753-3322(02)00193-2","volume":"56","author":"H Tapiero","year":"2002","unstructured":"Tapiero H, Ba GN, Couvreur P, Tew KD (2002) Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother 56:215\u2013222","journal-title":"Biomed Pharmacother"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1046\/j.1471-4159.2003.01917.x","volume":"86","author":"K Wakamatsu","year":"2003","unstructured":"Wakamatsu K, Fujikawa K, Zucca FA, Zecca L, Ito S (2003) The structure of neuromelanin as studied by chemical degradative methods. J Neurochem 86:1015\u20131023","journal-title":"J Neurochem"},{"key":"4_CR610","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","volume":"93","author":"A Yoritaka","year":"1996","unstructured":"Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 93:2696\u20132701","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR620","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrn1537","volume":"5","author":"L Zecca","year":"2004","unstructured":"Zecca L, Youdim MBH, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863\u2013873","journal-title":"Nat Rev Neurosci"}],"container-title":["Subcellular Biochemistry","Lipid Hydroperoxide-Derived Modification of Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-7920-4_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:28:01Z","timestamp":1746091681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-7920-4_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,11]]},"ISBN":["9789400779198","9789400779204"],"references-count":62,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-7920-4_4","relation":{},"ISSN":["0306-0225"],"issn-type":[{"type":"print","value":"0306-0225"}],"subject":[],"published":{"date-parts":[[2013,12,11]]},"assertion":[{"value":"11 December 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}